Cryosite Limited (ASX:CTE)

Market Cap	34.65M
Revenue (ttm)	12.85M
Net Income (ttm)	1.83M
Shares Out	48.81M
EPS (ttm)	0.04
PE Ratio	18.92
Forward PE	n/a
Dividend	0.02 (2.82%)
Ex-Dividend Date	n/a

Volume	700
Average Volume	6,779
Open	0.7100
Previous Close	0.7100
Day's Range	0.7100 - 0.7100
52-Week Range	0.6720 - 1.1300
Beta	0.34
RSI	33.45
Earnings Date	Aug 22, 2025

About Cryosite

Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through two segments: Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment offers specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns, biological, and cell gene therapies depot services. The Cord Blood and Tissues Storage segment provides long term storage...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1999
• Employees: 25
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CTE

Financial Performance

In 2024, Cryosite's revenue was 12.61 million, an increase of 5.67% compared to the previous year's 11.94 million. Earnings were 1.84 million, an increase of 30.59%.